Poolbeg Pharma Statistics

Total Valuation

Poolbeg Pharma has a market cap or net worth of 33.17 million. The enterprise value is 22.54 million.

Market Cap	33.17M
Enterprise Value	22.54M

Important Dates

The next estimated earnings date is Wednesday, June 18, 2025.

Earnings Date	Jun 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	500.00M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	588.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.86
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.11
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.79

Current Ratio	8.79
Quick Ratio	8.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.83% and return on invested capital (ROIC) is -32.21%.

Return on Equity (ROE)	-48.83%
Return on Assets (ROA)	-29.75%
Return on Invested Capital (ROIC)	-32.21%
Return on Capital Employed (ROCE)	-65.90%
Revenue Per Employee	n/a
Profits Per Employee	-453,040
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-192,796
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.57% in the last 52 weeks. The beta is 1.91, so Poolbeg Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.91
52-Week Price Change	-78.57%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	35.84
Average Volume (20 Days)	7,318

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.65M
Pretax Income	-7.44M
Net Income	-7.25M
EBITDA	-7.51M
EBIT	-7.65M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 9.80 million in cash and n/a in debt, giving a net cash position of 9.80 million.

Cash & Cash Equivalents	9.80M
Total Debt	n/a
Net Cash	9.80M
Net Cash Per Share	n/a
Equity (Book Value)	11.61M
Book Value Per Share	0.02
Working Capital	9.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.82M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Poolbeg Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-21.85%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1